Simris Group AB (PUBL) (STO:SIMRIS.B)
Sweden · Delayed Price · Currency is SEK 0.0972
-0.0033 (-3.28%)
May 21, 2026, 11:14 AM CET
Simris Group AB (PUBL) Company Description
Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally.
The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria.
It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.
Simris Group AB (PUBL)
| Country | Sweden |
| Founded | 2011 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 5 |
| CEO | Daniel Kubitza |
Contact Details
Address: HerrestadsvAegen 24A Hammenhög, 276 50 Sweden | |
| Phone | 46 4 14 44 50 50 |
| Website | simrisgroup.com |
Stock Details
| Ticker Symbol | SIMRIS.B |
| Exchange | Nasdaq Stockholm |
| Share Class | Class B Shares |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0008091664 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Daniel Kubitza | Interim Chief Executive Officer |
| Christoffer Tell | Chief Financial Officer |